Table 3.
Cost distribution among the control and TDM groups
| Cost type | Control group (n=56) | TDM group (n=10) | p value† | ||||
|---|---|---|---|---|---|---|---|
| Mean±SD (MYR) | Median (MYR) | Range (MYR) | Mean±SD (MYR) | Median (MYR) | Range (MYR) | ||
| Laboratory and clinical investigations* | 46.30±44.80 | 37.00 | 10.00 to 320.00 | 36.80±13.30 | 39.50 | 10.00 to 57.00 | 0.727 |
| Gentamicin dose | 9.90±5.30 | 8.50 | 3.70 to 31.40 | 10.30±6.20 | 8.40 | 4.40 to 23.90 | 0.865 |
| TDM service | - | - | - | 252.79±131.25 | 194.46 | 194.46 to 583.38 | - |
| Professional staff | 21.50±11.90 | 16.00 | 12.00 to 80.20 | 26.10±12.60 | 22.10 | 12.00 to 52.10 | 0.133 |
| Hospital stay during gentamicin therapy | 11.00±22.70 | 6.00 | 4.50 to 175.00 | 36.60±62.40 | 13.50 | 6.00 to 210.00 | 0.003 |
| Total | 86.33±72.15 | 75.82 | 20.92 to 525.36 | 362.66±156.56 | 276.56 | 260.21 to 706.70 | <0.001 |
*
In the control group (n=53).
†
Mann-Whitney test